Your browser doesn't support javascript.
loading
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
Tanabe, Hiroki; Yoshino, Keiichi; Ando, Katsuyoshi; Nomura, Yoshiki; Ohta, Katsuhisa; Satoh, Kiichi; Ichiishi, Eiichiro; Ishizuka, Akiei; Otake, Takaaki; Kohgo, Yutaka; Fujiya, Mikihiro; Okumura, Toshikatsu.
Afiliação
  • Tanabe H; Department of Gastroenterology, International University of Health and Welfare Hospital, Iguchi 537-3, Nasushiobara, Tochigi, 329-2763, Japan. tant@asahikawa-med.ac.jp.
  • Yoshino K; Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido, 078-8510, Japan. tant@asahikawa-med.ac.jp.
  • Ando K; Department of Gastroenterology, International University of Health and Welfare Hospital, Iguchi 537-3, Nasushiobara, Tochigi, 329-2763, Japan.
  • Nomura Y; Jiseikai-Kamiitabashi Hospital, 4-36-9 Tokiwadai Itabashi-ku, Tokyo, 174-0071, Japan.
  • Ohta K; Department of Gastroenterology, International University of Health and Welfare Hospital, Iguchi 537-3, Nasushiobara, Tochigi, 329-2763, Japan.
  • Satoh K; Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido, 078-8510, Japan.
  • Ichiishi E; Department of Gastroenterology, International University of Health and Welfare Hospital, Iguchi 537-3, Nasushiobara, Tochigi, 329-2763, Japan.
  • Ishizuka A; Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido, 078-8510, Japan.
  • Otake T; Department of Gastroenterology, International University of Health and Welfare Hospital, Iguchi 537-3, Nasushiobara, Tochigi, 329-2763, Japan.
  • Kohgo Y; Department of Gastroenterology, International University of Health and Welfare Hospital, Iguchi 537-3, Nasushiobara, Tochigi, 329-2763, Japan.
  • Fujiya M; Department of Gastroenterology, International University of Health and Welfare Hospital, Iguchi 537-3, Nasushiobara, Tochigi, 329-2763, Japan.
  • Okumura T; Department of Gastroenterology, International University of Health and Welfare Hospital, Iguchi 537-3, Nasushiobara, Tochigi, 329-2763, Japan.
Ann Clin Microbiol Antimicrob ; 17(1): 29, 2018 Jun 28.
Article em En | MEDLINE | ID: mdl-29950163
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Plantas_medicinales Assunto principal: Pirróis / Sulfonamidas / Helicobacter pylori / Infecções por Helicobacter / Claritromicina / Inibidores da Bomba de Prótons / Amoxicilina / Antibacterianos Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: Ann Clin Microbiol Antimicrob Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Plantas_medicinales Assunto principal: Pirróis / Sulfonamidas / Helicobacter pylori / Infecções por Helicobacter / Claritromicina / Inibidores da Bomba de Prótons / Amoxicilina / Antibacterianos Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: Ann Clin Microbiol Antimicrob Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão